The life sciences industry and regulators around the world are facing many challenges in protecting the safety of patients. Poor visibility across the supply chain has led to proliferation of drug-related criminal activities such as drug counterfeiting, illegal diversion, and theft. It has also caused inefficiencies to surface across supply chain functions. This not only hampers the brand equity of pharmaceutical companies but also puts the life of patients in serious danger. Therefore, serialization laws are fast becoming mandates in many countries.

Parag Agrawal in his white paper discusses the various aspects of Counterfeiting menace.

Download the full paper by signing in 

94B0191F D0AA 61C4 CB9AE4E42BCBCD66

About the author

Parag Agrawal

A packaging technocrat from SIES School of packaging, PG diploma in business administration with specialization in marketing, & graduate in science from Mumbai University, Parag Agrawal has 15 years of experience in Packaging Industry Domain in areas of Sales, Marketing & Product portfolio management.

He is associated with Holostik India as a General Manager – Technical Sales for Labels Business Division. In his earlier roles, He was associated with Avery Dennison India as a Product Manager -SAPSSA for Specialties, Durables & SMART Labels portfolio working with external & internal customers to identify the product & application related challenges & create relevant solutions. He has also served companies like TCPL Packaging & Vora Packaging Pvt. Ltd. to help them drive sales & marketing for national & international markets in his previous tenure

OTHER WHITE PAPERS

Want to write for us?